2Duncan J,Campbell.The Kallikrein-kinin system in humans[J].Clinical and Experimental Pharmacology and Physiology,2001,28:1060-1065.
3Deshamdra M, Raidoo, Kanti D. Pathophysilolgy of kallikrein-kinin system in mammalian nervous tissue [J]. Pharmacol Ther, 1998,79:105-129
4Ding-Zhou L, Margaill I, Palmier B. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia[J]. Br J Pharmacol, 2003,139:1539-1547
5Chao J, Chao L. Experimental therapy with tissue kallikrein against cerebral ischemia[J]. Front Biosci, 2006,1:1323-1327
6Souza DG, Pinho V, Pesquero JL, et al. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury[J]. Br J Pharmacol, 2003,139:129-139
7Kamiya T, Katayama Y, Kashiwagi F, et al .The role of bradykinin in mediating ischemic brain edema in rats[J]. Stroke ,1993,24:571-575
8Noda M, Kariura Y, Amano T, et al. Expression and function of bradykinin receptors in microglia[J]. Life Sciences, 2003,72:1573-1581
9Groger M, Lebesgue D, Pruneau D, et al. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice[J]. Journal of Cerebral Blood Flow & Metabolism, 2005,25:978-989
10Marceau F, Hess JF, Bachvarov. The B1 receptors for kinins[J]. Pharmacol Rev, 1998, 50:357-386
